Journals / İstanbul Medical Journal / 2016 / Cilt: 17 - Sayı: 1

Epstein-Barr Virus and DNA Methylation in Gastric Cancer

Epstein-Barr Virüsü ve Gastrik Kanserde DNA Metilasyonu

Pages
1–4
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the current literature about the gene promotor region hypermethylation in EBVaGCs will be revised.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastric cancer (GC) is the fourth most common type of malignity and the sec- ond leading cause of cancer death worldwide.
📊
Key Findings & Data:EBV is a double-stranded DNA virus, approximality 184 kb in size, included in Herpes virus family and is the first virus determined in human neoplastic cell.
💡
Conclusion & Impact:In this review, the current literature about the gene promotor region hypermethylation in EBVaGCs will be revised.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gastric cancer (GC) is the fourth most common type of malignity and the sec- ond leading cause of cancer death worldwide. Infectious agents such as He- licobacter pylori (H.pylori) and Epstein-Barr virus (EBV) play important role in the etiology in GC. EBV is a double-stranded DNA virus, approximality 184 kb in size, included in Herpes virus family and is the first virus determined in human neoplastic cell. EBV associated gastric cancer (EBVaGC) constitutes approximately 10% of whole GC in wordlwide. DNA hypermethylation in promotor region of tumor supressor genes is seen frequently in the genetic basis of EBCaGC. It is not a clear subject how EBV infection induce the meth- ylation. In this review, the current literature about the gene promotor region hypermethylation in EBVaGCs will be revised.

Özet

Gastrik kanser (GK) tüm dünyada görülme sıklığı yönünden dördüncü ve kanserle ilişkili ölümlerde ikinci sırayı alan bir malignitedir. GK etyolojisinde Helikobakter pilori (H. pilori) ve Epstein-Barr virüs (EBV) gibi enfeksiyon ajanlar önemli rol oynamaktadır. EBV Herpes virüs ailesinden, yaklaşık 184 kb boyutunda, çift-dallı DNA virüsüdür ve insan neoplastik hücrelerinde saptanmış olan ilk virüstür. EBV ilişkili gastrik kanser (EBViGK) tüm dünyadaki gastrik kanserlerin yaklaşık %10'nu oluşturur. EBViGK'lerinin genetik temelinde tümör baskılayıcı genlerin promotor bölgesinde DNA hipermetilasyonu sık görülmektedir. EBV enfeksiyonunun metilasyonu nasıl indüklediği tam olarak aydınlatılamamış bir konudur. Bu derlemede, EBViGK'lerdeki gen promotor bölge hipermetilasyonu hakkındaki son literatür gözden geçirilecektir.

🔖

Cite This Article

NURSAL, A. F. (2022). Epstein-Barr Virus and DNA Methylation in Gastric Cancer. İstanbul Medical Journal, Cilt: 17 - Sayı: 1, 1–4. https://ajindex.com/articles/552138

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ryan JL, Jones RJ, Kenney SC, Rivenbark AG, Tang W, Knight ER, et al. Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infect Agent Cancer 2010
  2. [CrossRef] Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K. Methyla- tion-mediated gene silencing as biomarkers of gastric cancer: a re- view. World J Gastroenterol 2014
  3. 11991-2006. [CrossRef] Park JY, von Karsa L, Herrero R. Prevention strategies for gastric can- cer: a global perspective. Clin Endosc 2014
  4. [CrossRef] Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014
  5. 13804-19. [CrossRef] Matsusaka K, Funata S, Fukayama M, Kaneda A. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol 2014
  6. [CrossRef] Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta 2013
  7. [CrossRef] Kaneda A, Matsusaka K, Aburatani H, Fukayama M. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res 2012
  8. [CrossRef] Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses 2012
  9. [CrossRef] Yau TO, Tang CM, Yu J. Epigenetic dysregulation in Epstein-Barr virus- associated gastric carcinoma: disease and treatments. World J Gastro- enterol 2014
  10. [CrossRef] 3 Tse E, Kwong YL. Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target. Exp Mol Med 2015
  11. [CrossRef] Khan G, Hashim MJ. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010. Infect Agent Cancer 2014
  12. [CrossRef] Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int 2010
  13. [CrossRef] Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol 2015
  14. [CrossRef] Li L, Zhang Y, Guo BB, Chan FK, Tao Q. Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells. Chin J Cancer 2014
  15. [CrossRef] Geddert H, Zur Hausen A, Gabbert HE, Sarbia M. BV-infection in car- diac and non-cardiac gastric adenocarcinomas is associated with pro- moter methylation of p16, p14 and APC, but not hMLH1. Anal Cell Pathol (Amst) 2010
  16. [CrossRef] Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, et al. p73 gene promoter methylation in Epstein-Barr virus-associa